20 June 2013
Keywords: Sanofi, :ixissenatide, Type 2 diabetes, USA, FDA, Zealand Pharma
Article | 19 February 2013
The US Food and Drug Administration has accepted for review French drug major Sanofi’s (Euronext: SAN) New Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 February 2013
19 June 2013
© 2013 thepharmaletter.com